Skip to main content

Advertisement

SpringerLink
Log in

Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia

  • Leukemia (A Aguayo, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Many prognostic and predictive biomarkers have been proposed for chronic lymphocytic leukaemia (CLL). Here, we aim to discuss the evidence showing a prognostic potential for extracellular vesicles (EV) and their associated microRNAs (miRNAs).

Recent Findings

EV are produced by several cells in the body as a physiological event; however, there is evidence suggesting that an elevated EV concentration is present in the circulation of CLL patients. Moreover, some studies have associated EV concentration with advanced Rai stage and unmutated CLL while others have demonstrated its potential as an independent prognostic factor for TTFT and OS. Finally, some studies have shown that CLL EV shared some dysregulated microRNAs with CLL cells and plasma. On the other hand, it was found that CLL EV has a distinctive microRNA expression profile. Until now, EV-associated miR-155 is the most studied miRNA.

Summary

Despite methodological diversity and limitations in study design, unanimity in CLL EV concentration behaviour and miRNA content has been found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol. 2007 Dec;139(5):809–19.

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.

    Article  PubMed  Google Scholar 

  3. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed: World Health Organization; 2017.

  4. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910–6.

    Article  PubMed  Google Scholar 

  5. Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, Citarella F, et al. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgVH unmutated chronic lymphocytic leukemia (CLL) cells. Blood. 2008;112(3):782–92.

    Article  CAS  PubMed  Google Scholar 

  6. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2011;117(2):563–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG, et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med. 2013;210(11):2273–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975 Aug;46(2):219–34.

    Article  CAS  PubMed  Google Scholar 

  9. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981 Jul;48(1):198–206.

    Article  CAS  PubMed  Google Scholar 

  10. Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R. Chlorambucil in indolent chronic lymphocytic leukemia French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med. 1998;338:1506–14.

    Article  CAS  PubMed  Google Scholar 

  11. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999 Sep;94(6):1848–54.

    Article  CAS  PubMed  Google Scholar 

  12. Parikh SA, Strati P, Tsang M, West CP, Shanafelt TD. Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis. Blood. 2016;127(14):1752–60.

    Article  CAS  PubMed  Google Scholar 

  13. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–89.

    Article  CAS  PubMed  Google Scholar 

  14. Théry C, Witwer KW, Aikawa E, Jose Alcaraz M, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018 Nov 23;7(1):1535750.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Iavello A, Frech VSL, Gai C, Deregibus MC, Quesenberry PJ, Camussi G. Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med. 2016;37(4):958–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ageta H, Ageta-Ishihara N, Hitachi K, Karayel O, Onouchi T, Yamaguchi H, et al. UBL3 modification influences protein sorting to small extracellular vesicles. Nat Commun. 2018;9(1):1–3.

    Article  CAS  Google Scholar 

  17. Chiou NT, Kageyama R, Ansel KM. Selective export into extracellular vesicles and function of tRNA fragments during T cell activation. Cell Rep [Internet]. 2018;25(12):3356–3370.e4.

    Article  CAS  Google Scholar 

  18. Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: Unique intercellular delivery vehicles. Trends Cell Biol. 2017 Mar;27(3):172–88.

    Article  CAS  PubMed  Google Scholar 

  19. Keller S, Ridinger J, Rupp AK, Janssen JWG, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med. 2011;9:1–9.

    Article  Google Scholar 

  20. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zheng X, Xu K, Zhou B, Chen T, Huang Y, Li Q, et al. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. J Extracell vesicles. 2020;9(1):1750202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hong C-S, Muller L, Whiteside TL, Boyiadzis M, Mukhopadhyay B, Johnson J et al. Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia. 2011; 10;5:160.

  23. Caivano A, La Rocca F, Simeon V, Girasole M, Dinarelli S, Laurenzana I, et al. MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies — a short report. Cell Oncol (Dordr). 2017 Feb;40(1):97–103.

    Article  CAS  Google Scholar 

  24. Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol [Internet]. 2019;20(1):21–37.

    Article  CAS  Google Scholar 

  25. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem [Internet]. 2011;67(1):129–39.

    Article  CAS  Google Scholar 

  26. Deddens JC, Vrijsen KR, Colijn JM, Oerlemans MI, Metz CHG, van der Vlist EJ, et al. Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury. J Cardiovasc Transl Res [Internet]. 2016;9(4):291–301.

    Article  Google Scholar 

  27. de Miguel PD, Rodriguez Martínez A, Ortigosa Palomo A, Delgado Ureña M, Garcia Puche JL, Robles Remacho A, et al. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients. Sci Rep [Internet]. 2020;10(1):3974.

    Article  Google Scholar 

  28. Reiners KS, Shatnyeva O, Vasyutina E, Bösl T, Hansen HP, Hallek M, et al. Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells. Haematologica. 2017;102:e100–3.

  29. Paggetti J, Haderk F, Seiffert M, Janji B, Distler U, Ammerlaan W, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015 Aug;126(9):1106–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ghosh AK, Secreto CR, Knox TR, Ding W, Mukhopadhyay D, Kay NE. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood [Internet]. 2010 Mar 4;115(9):1755–64.

    Article  CAS  Google Scholar 

  31. Haderk F, Schulz R, Iskar M, Cid LL, Worst T, Willmund KV, et al. Tumor-derived exosomes modulate PD-L1 expression in monocytes. Sci Immunol. 2017;2(13) This paper elucidated the small RNA content by NGS of EV isolated from plasma of CLL patients. This confirmed the abundance of Y RNA and microRNA in the mixture of EV.

  32. Gargiulo E, Morande P, Janji B, Paggetti J, Moussay E. Impact of small extracellular vesicles in chronic lymphocytic leukaemia microenvironment. Poster presented at: 25th European Hematology Association Annual Congress; 2020, June 11-21; Virtual Edition. This paper is relevant as it shows in an in vivo model that the presence of reduced CLL EV delays the development of the malignancy. This confirms in vitro experiements showing phenotypic changes in different types of bystander cells caused by CLL EV.

  33. Smallwood DT, Apollonio B, Willimott S, Lezina L, Alharthi A, Ambrose AR, et al. Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells. Blood. 2016 Jul;128(4):542–52.

    Article  CAS  PubMed  Google Scholar 

  34. Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumor Biol. 2015;36(12):9739–52.

    Article  CAS  Google Scholar 

  35. Yeh YY, Ozer HG, Lehman AM, Maddocks K, Yu L, Johnson AJ, et al. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood. 2015;125(21):3297–305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. De Luca L, D’Arena G, Simeon V, Trino S, Laurenzana I, Caivano A, et al. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Leuk Lymphoma. 2017;58(6):1424–32 First study evaluating the prognostic value of CLL EV in the prediction of TTFT and OS in CLL patients.

    Article  PubMed  Google Scholar 

  37. Stevenson FK, Krysov S, Davies AJ, Steele AJ, Packham G. B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2011 Oct;118(16):4313–20.

    Article  CAS  PubMed  Google Scholar 

  38. Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 2007 May;109(10):4424–31.

    Article  CAS  PubMed  Google Scholar 

  39. Boysen J, Nelson M, Magzoub G, Maiti GP, Sinha S, Goswami M, et al. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. Leukemia. 2017;31(2):350–60 This paper associates EV concentration in plasma of patients with CLL to IGHV status. They also studied the effect of BTK inhibition in EV release allowing the association of EV secretion to BCR activation.

    Article  CAS  PubMed  Google Scholar 

  40. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999 Sep;94(6):1840–7.

    Article  CAS  PubMed  Google Scholar 

  41. Stevenson FK, Sahota SS, Ottensmeier CH, Zhu D, Forconi F, Hamblin TJ. The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res. 2001;83:81–116.

    Article  CAS  PubMed  Google Scholar 

  42. Aguilar-Hernandez MM, Blunt MD, Dobson R, Yeomans A, Thirdborough S, Larrayoz M, et al. IL-4 enhances expression and function of surface IgM in CLL cells. Blood. 2016 Jun;127(24):3015–25.

    Article  CAS  PubMed  Google Scholar 

  43. Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, et al. Micro RNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014;124(4):546–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Rossi D, Gerber B, Stüssi G. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia. Leuk Lymphoma. 2017 Jul;58(7):1548–60.

    Article  CAS  PubMed  Google Scholar 

  45. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002 Nov;99(24):15524–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011 Dec;717(1–2):1–8.

    Article  CAS  PubMed  Google Scholar 

  47. Cohen JA, Bomben R, Pozzo F, Tissino E, Härzschel A, Hartmann TN, et al. An updated perspective on current prognostic and predictive biomarkers in chronic lymphocytic leukemia in the context of chemoimmunotherapy and novel targeted therapy. Cancers (Basel). 2020;12(4):1–17.

    Article  Google Scholar 

  48. Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, et al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9(2).

  49. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun;9(6):654–9.

    Article  CAS  PubMed  Google Scholar 

  51. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci. 2011;108(12):5003–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011 Apr;13(4):423–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Moussay E, Wang K, Cho JH, Van Moer K, Pierson S, Paggetti J, et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2011;108(16):6573–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Farahani M, Rubbi C, Liu L, Slupsky JR, Kalakonda N. CLL exosomes modulate the transcriptome and behaviour of recipient stromal cells and are selectively enriched in MIR-202-3p. PLoS One. 2015;10(10):1–18.

    Article  Google Scholar 

  55. Alharthi A, Beck D, Howard DR, Hillmen P, Oates M, Pettitt A, et al. An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects. BMC Res Notes [Internet]. 2018;11(1):1–7.

    Google Scholar 

  56. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013;122(11):1891–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, et al. Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome. Crit Rev Clin Lab Sci. 2018 Nov;55(7):501–15.

    Article  CAS  PubMed  Google Scholar 

  58. Gutiérrez García G, Galicia García G, Zalapa Soto J, Izquierdo Medina A, Rotzinger-Rodríguez M, Casas Aguilar GA, et al. Analysis of RNA yield in extracellular vesicles isolated by membrane affinity column and differential ultracentrifugation. PLoS One. 2020;15(11):e0238545.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Hematología, Catedra CONACYT, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Avenida Vasco de Quiroga No. 15, Colonia Belisario Domínguez Sección XVI, Delegación Tlalpan C.P, 14080, Mexico City, Mexico

    Maria Montserrat Aguilar-Hernandez

  2. Departamento de Hematología, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Avenida Vasco de Quiroga No. 15, Colonia Belisario Domínguez Sección XVI, Delegación Tlalpan C.P, 14080, Mexico City, Mexico

    Julio César Rincon Camacho & Gabriela Galicia Garcia

Authors
  1. Maria Montserrat Aguilar-Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julio César Rincon Camacho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriela Galicia Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Montserrat Aguilar-Hernandez.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

None of the authors has any conflicts of interest to disclose

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Leukemia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aguilar-Hernandez, M.M., Rincon Camacho, J.C. & Galicia Garcia, G. Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia. Curr Oncol Rep 23, 66 (2021). https://doi.org/10.1007/s11912-021-01058-2

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11912-021-01058-2

Keywords

Search

Navigation